Literature DB >> 24369994

Potential of two nucleic acid amplification assays for quantifying mycobacterial load in respiratory and non-respiratory specimens: a prospective study.

Amani Mansour Alnimr1, Manal Ismail Hassan2.   

Abstract

Quantification of bacillary load plays a critical prognostic role in tuberculosis patients. This study evaluated the potential of the Cepheid GeneXpert (GX) MTB/RIF and the BD ProbeTec system as quantitative assays. The time to positivity (TTP) measured by the Mycobacterial Growth Index Tube system was compared to the cycle threshold (Ct) of GX MTB/RIF and the Metric Other than Acceleration (MOTA) scores generated by the ProbeTec system. Out of 714 samples examined, 44 culture confirmed cases were identified. The Ct values in 21 respiratory samples showed a high linear fit with the TTP in liquid culture (Spearman's correlation coefficient r = 0.9, P value < 0.0001), which was not the case in 23 non-respiratory samples. In both types of specimens, the MOTA scores did not correlate with the TTP in liquid culture. This indicates the suitability of GX as a quantitative measurement of mycobacterial load in respiratory but not non-respiratory specimens. Crown
Copyright © 2014. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GeneXpert; ProbeTec; Time-to-positive culture; Tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 24369994     DOI: 10.1016/j.diagmicrobio.2013.11.020

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2019-06-07

2.  Performance Comparison of GeneXpert MTB/RIF and ProbeTec ET Tests for Rapid Molecular Diagnosis of Extrapulmonary Tuberculosis in a Low TB/MDR-TB Incidence Country.

Authors:  Eiman Mokaddas; Suhail Ahmad; Hanaa Eldeen
Journal:  Med Princ Pract       Date:  2021-02-16       Impact factor: 1.927

3.  The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis.

Authors:  Alison S Devonshire; Denise M O'Sullivan; Isobella Honeyborne; Gerwyn Jones; Maria Karczmarczyk; Jernej Pavšič; Alice Gutteridge; Mojca Milavec; Pablo Mendoza; Heinz Schimmel; Fran Van Heuverswyn; Rebecca Gorton; Daniela Maria Cirillo; Emanuele Borroni; Kathryn Harris; Marinus Barnard; Anthenette Heydenrych; Norah Ndusilo; Carole L Wallis; Keshree Pillay; Thomas Barry; Kate Reddington; Elvira Richter; Erkan Mozioğlu; Sema Akyürek; Burhanettin Yalçınkaya; Muslum Akgoz; Jana Žel; Carole A Foy; Timothy D McHugh; Jim F Huggett
Journal:  BMC Infect Dis       Date:  2016-08-03       Impact factor: 3.090

4.  Identification of Novel RD1 Antigens and Their Combinations for Diagnosis of Sputum Smear-/Culture+ TB Patients.

Authors:  Zhiqiang Liu; Shuang Qie; Lili Li; Bingshui Xiu; Xiqin Yang; Zhenhua Dai; Xuhui Zhang; Cuimi Duan; Haiping Que; Ping Zhao; Heather Johnson; Heqiu Zhang; Xiaoyan Feng
Journal:  Biomed Res Int       Date:  2016-01-18       Impact factor: 3.411

Review 5.  Molecular Diagnosis of Tuberculosis.

Authors:  Fariz Nurwidya; Diah Handayani; Erlina Burhan; Faisal Yunus
Journal:  Chonnam Med J       Date:  2018-01-25

6.  Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa.

Authors:  Fenella Beynon; Grant Theron; Durval Respeito; Edson Mambuque; Belen Saavedra; Helder Bulo; Sergi Sanz; Keertan Dheda; Alberto L Garcia-Basteiro
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.